- About TDL
- Services & Divisions
- Test Information
- Contact Us
Chromosomal abnormalities may be somatic cell in origin, in which case they can be detected by a simple blood karyotype analysis. However, most sperm chromosome anomalies arise as a result of errors during meiosis, which cannot be detected by a blood karyotype analysis. These anomalies can only be detected by looking at the sperm chromosomes directly.
Approximately 2 to 13% of all sperm are genetically abnormal in normally fertile men however this percentage may be 3 times higher in men who are infertile1-4. Aneuploidy rates in sperm of men with poor semen parameters are between 2 to 10 times higher that of fertile men4 although men with normal semen parameters may also display high levels of aneuploidy3,5. This may partly explain why there are conflicting results regarding direct correlations between individual semen parameters and sperm aneuploidy. There is general agreement that the frequency of sperm aneuploidy is particularly high in men with severe sperm defects1,2,6,7. High rates of aneuploidy are found in severe asthenozoospermia6, severe oligozoospermia1,3,7 and in testicular sperm from men with non-obstructive azoospermia8,9. In approximately 1% cases of male infertility, men are diagnosed with a predominant morphological defect in their sperm, namely globozoospermia (round headed sperm), macrozoospermia (sperm with enlarged heads and multiple tails) or dysplasia of the fibrous sheath (severe tail defects). Sperm from men with these defects show a significant increase in sperm aneuploidy2,4,10 and generally have a very poor prognosis for IVF/ICSI treatment11,12. Globozoospermia may have an increased frequency of aneuploidy 8 to 10 times13, sperm with dysplasia of the fibrous sheath 2 to 12 times12,14 and sperm with tapered heads 1.6 to 3.6 times15 that of normal sperm. Macrocephalic sperm are especially prone to aneuploidy showing aneuploidy frequencies between 10 and 30 times that of controls and between 20 and 90% of these sperm may be aneuploid11,13. The frequency of aneuploidy is greatest in sperm from men who have severe defects in all major semen parameters4,16,17. Indeed sperm from men with oligoasthenoteratozoospermia are up to 30 times more likely to be aneuploid4.
A high rate of sperm aneuploidy leads to a significant increase in the occurrence of chromosome aneuploidy in embryos 18-21. The consequences of this are poor embryo development, a significantly reduced pregnancy rate, and an increased risk of abnormalities in newborns. Sperm aneuploidy influences ICSI treatment outcome and is associated with multiple assisted conception treatment failure22. The incidence of aneuploidy was found to be significantly higher in sperm of men who are unsuccessful with ICSI treatment compared to those who achieve pregnancies23,24. Furthermore, there are numerous studies that show a significant correlation between sperm aneuploidy and recurrent pregnancy loss 3,18, 25-27 irrespective of whether the semen parameters are normal 27.
Sperm aneuploidy occurs due to increased errors in meiotic pairing, synapsis and recombination during sperm development2,28 . In patients who have an abnormal blood chromosome karyotype, such as Klinefelter's, their sperm have an increased incidence of aneuploidy but the rates are not as high as expected2,28. It has been suggested that advancing paternal age may be linked to sperm aneuploidy but only a slight increased risk of aneuploidy has been found29. The effects of specific lifestyle factors on aneuploidy frequencies are inconsistent, and this is likely due to the difficulty in controlling for other factors as well as variation between individuals. However most studies show a strong association between cigarette smoking and aneuploidy2,17,30-32 and there is some evidence relating sperm aneuploidy to alcohol consumption30, caffeine consumption32,33 and obesity33. High levels of sperm aneuploidy can also be caused by exposure to pesticides34,35 and occupational hazards36. It is well established that sperm from men who have been treated with chemotherapy and radiotherapy have a significant increase in aneuploidy37,38 which leads to an increased risk of impaired embryo development, miscarriage and congenital abnormalities in the children born38. This risk appears to be mitigated within 18 months to two years post treatment37.
Assessment of sperm aneuploidy involves fluorescent in situ hybridisation (FISH) to label individual chromosomes with specific probes39. One to two thousand sperm can be assessed from one ejaculate. The assay has been standardised and validated and is CE marked. There are limitations to the test as it will only determine numerical chromosome anomalies and cannot provide any information about structural abnormalities or single gene defects. Only 5 probes are currently used routinely for analysis (three of the 22 autosomes: chromosomes 13, 18 and 21, and the sex chromosomes, X and Y) as these chromosomes are the most susceptible to non-disjunction during meiosis2,18,39. They are also most important from a clinical perspective as they may be non-lethal and are compatible with survival40. Probes for other chromosomes are available upon specific request. The results are reported showing incidence of disomy or nullisomy for each of the autosomes and for both sex chromosomes compared to a reference range determined from fertile controls. A sex chromosome ratio and diploidy rate is also reported. The turnaround time for the results is between 10 and 14 days.
The clinical implementation of sperm chromosome aneuploidy testing may be recommended for men with severe male factor infertility, especially when this has resulted in multiple failed ICSI treatment cycles or recurrent pregnancy loss2,4,40. Sperm aneuploidy testing should be performed in cases of severe defects in sperm morphology such as macrocephaly, globozoospermia and dysplasia of the fibrous sheath. The test is also recommended for men with normal semen parameters who experience unexplained assisted conception treatment failure or recurrent miscarriage in their partners3,40.
A reduction in exposure to harmful substances and a change in diet and lifestyle may help to reduce high frequencies of aneuploidy in sperm. One study demonstrated that diet supplementation with high folate may maintain lower aneuploidy rates41. However, some abnormalities may be irreversible. Particular types of severe sperm morphological abnormalities are themselves associated with gene defects which cannot be treated11. An alternative management strategy would be to implement sperm selection methods to identify sperm more likely to be chromosomally normal. A recent randomised controlled trial has shown very promising results using hyaluronan to select genetically healthy sperm for ICSI treatment42. When there is a substantial risk of transmitting chromosomal defects to the offspring, preimplantation genetic screening of embryos following ICSI may be offered40.
Sperm aneuploidy testing may provide valuable information to assist in the diagnosis and management of male infertility, not only as a predictor of success, but for future genetic counselling for the couple. In cases of multiple IVF or ICSI treatment failure as well as for unexplained recurrent miscarriage18, identification of chromosome abnormalities in the sperm may guide the clinician as to whether sperm donation may be appropriate. Sperm aneuploidy testing may help couples to make an informed choice regarding their subsequent course of treatment. Couples who may be at an increased risk of recurrent pregnancy loss or passing on chromosomal abnormalities to their children may opt for sperm selection using hyaluronon or preimplantation genetic screening of their embryos thus increasing their chances of a healthy live birth.
Additional information downloads:
Sperm DNA Fragmentation and Aneuploidy/Sample Information Sheet and Request Form (Word doc, 56Kb)
1. Sarrate Z, Vidal F, Blanco J (2010) Role of sperm fluorescent in situ hybridization studies in infertile patients: indications, study approach, and clinical relevance. Fertil Steril 93:1892–1902
2. Templado C, Uroz L, Estop A (2013) New insights on the origin and relevance of aneuoploidy in humanspermatozoa. Mol Hum Reprod 19(10):634-43.
3. Ramasamy R, Scovell JM, Kovac JR, Cook PJ, Lamb DJ, Lipshultz LI (2015) Fluorescence in situ hybridization detects increased sperm aneuploidy in men with recurrent pregnancy loss. Fertil Steril 103(4):906-909
4. Ioannou D, Miller D, Griffin DK, Tempest HG (2016) Impact of sperm DNA chromatin in the clinic J Assist Reprod Genet (2016) 33:157–166
5. Celik-Ozenci C, Jakab A, Kovacs T, Catalanotti J, Demir R, Bray-Ward P, Ward D and Huszar G (2004) Sperm selection for ICSI: shape properties do not predict the absence or presence of numerical chromosomal aberrations. Human Reprod. 19 (9):2052-2059
6. Tempest HG, Homa ST, Dalakiouridou M, Christopikou D, Wright D, Zhai XP, Griffin DK (2004) The association between male infertility and sperm disomy: Evidence for variation in disomy levels among individuals and a correlation between particular semen parameters and disomy of specific chromosome pairs. Reprod Biol Endocrinol 2:82
7. Durak Aras B, Aras I, Can C, Toprak C, Dikoglu E, Bademci J, Ozdemir M, Cilingir O, Artan S (2012) Exploring the relationship between the severity of oligozoospermia and the frequencies of sperm aneuploidies. Andrologia 44:416–422
8. Sun F, Mikhaail-Philips M, Oliver-Bonet M, Ko E, Rademaker A, Turek P, Martin RH (2008) Reduced meiotic recombination on the XY bivalent iscorrelated with an increased incidence of sex chromosome aneuploidyin men with non-obstructive azoospermia. Mol Hum Reprod 14:399–404.
9. Rodrigo L, Rubio C, Peinado V, Villamon R, Al-Asmar N, Remohi J, Pellicer A, Simon C, Gil Salom M (2011) Testicular sperm from patients with obstructive and nonobstructive azoospermia: aneuploidy risk and reproductive prognosis using testicular sperm from fertile donors as control samples. Fertil Steril 95(3): 1005 - 1012
10. Sun F, Ko E, Martin RH (2006) Is there a relationship between sperm chromosome abnormalities and sperm morphology? Reprod Biol Endocrinol 4:1
11. De Braekeleer M, Nguyen MH, Morel F, Perrin A (2015) Genetic aspects of monomorphic teratozoospermia: a review. J Assist Reprod Genet 32(4):615-23.
12. Ghedir H, Mehri A, Mehdi M, Brahem S, Saad A, Abala-Romdhane S (2014) Meiotic segregation and sperm DNA fragmentation in Tunisian men with dysplasia of the fibrous sheath (DFS) associated with head abnormalities. J Assist Reprod Genet 31(9):1167-74
13. Brahem S, Elghezal H, Ghedir H, landolsi H, Amara A, Ibala S, Gribaa M, Saad A, Mehdi M (2011) Cytogenetic and molecular aspects of absolute teratozoospermia: Comparison between polymorphic and monomorphicforms. Urology 78:1313–1319.
14. Baccetti B, Collodel G, Gambera L , Moretti E, Serafini F, Piomboni P (2005) Fluorescence in Situ Hybridization and Molecular Studies in Infertile Men With Dysplasia of the Fibrous Sheath Fertil Steril 84 (1), 123-129.
15. Prisant N, Escalier D, Soufir J-C, Morillon M, Schoevaert D, Misrahi M, Tachdjian G (2007) N. Prisant Ultrastructural nuclear defects and increased chromosome aneuploidies in spermatozoa with elongated heads Hum Reprod (2007) 22 (4): 1052-1059.
16. Durakbasi-Dursun HG, Zamani AG, Kutlu R, Gorkemli H, Bahce M, Acar A (2008) A new approach to chromosomal abnormalities in sperm from patients with oligoasthenoteratozoospermia: detection of double aneuploidy in addition to single aneuploidy and diploidy by five-color fluorescence in situ hybridization using one probe set. Fertil Steril. 89(6):1709–17.
17. Faure AK, Aknin-Seifer I, Frérot G, Pelletier R, De Robertis C, Cans C, Levy R, Jimenez C, Lejeune H, Terrier N, Bergues U, Hennebicq S, Rousseaux S (2007) Predictive factors for an increased risk of sperm aneuploidies in oligo-astheno-teratozoospermic males. Int J Androl. 30(3):153-62.
18. Carrell DT (2008) The Clinical Implementation of Sperm Chromosome Aneuploidy Testing: Pitfalls and Promises. J Androl 29:124–133
19. Harton, GL and Tempest, HG (2012) Chromosomal disorders and male infertility. Asian J Androl. 14 (1):32-9.
20. Chatziparasidou A, Christoforidis N, Samolada G, Nijs M (2015) Sperm aneuploidy in infertile male patients: a systematic review of the literature Andrologia 47(8): Pages 847–860
21. Coates A, Hesla JS, Hurliman A, Coate B, Holmes E, Matthews R, Mounts EL, Turner KJ, Thornhill AR, Griffin DK (2015) Use of suboptimal sperm increases the risk of aneuploidy of the sex chromosomes in preimplantation blastocyst embryos. Fertil Steril 104(4):866-72
22. Rubio C, Gil-Salom M, Simon C,Vidal F, Rodrigo L, Minguez Y, Remohi J, Pellocer A (2001) Incidence of sperm chromosomal abnormalities in a risk population: relationship with sperm quality and ICSI outcome. Hum Reprod 16: 2084 - 2092
23. Burrello N, Vicari E, Shin P, Agarwal A, De Palma A, Grazioso C, D'Agata R, Calogero AE. (2003) Lower sperm aneuploidy frequency is associated with high pregnancy rates in ICSI programmes. Hum Reprod. 18 (7): 1371-6.
24. Nicopoullos JD, Gilling-Smith C, Almeida PA, Homa S, Nice L, Tempest H, Ramsay JWA (2008) The role of sperm aneuploidy as a predictor of the success of intracytoplasmic sperm injection? Hum Reprod 23: 240–50
25. Ghoraeian P, Mozdarani H, Aleyasin A, Alizadeh-Nili H (2013) Frequency of sex chromosomal disomy in spermatozoa of normal and oligozoospermic Iranian patients and its effects on fertilisation and implantation rates after ICSI. Andrologia 45(1):46-55.
26. Caseiro AL, Regalo A, Pereira E, Esteves T, Fernandes F, Carvalho J. (2015) Implication of sperm chromosomal abnormalities in recurrent abortion and multiple implantation failure. Reprod Biomed Online 31(4):481-5
27. Zidi-Jrah I, Hajlaoui A, Mougou-Zerelli S, Kammoun M, Meniaoui I, Sallem A, Brahem S, Fekih M, Bibi M, Saad A, Ibala-Romdhane Fertil Steril. (2016) Relationship between sperm aneuploidy, sperm DNA integrity, chromatin packaging, traditional semen parameters, and recurrent pregnancy loss. Fertil Steril 105(1):58-64
28. Tempest HG (2011) Meiotic recombination errors, the origin of sperm aneuploidy and clinical recommendations Syst Biol Reprod Med 57:93 - 101
29. Fonseka KG, Griffin DK (2011) Is there a paternal age effect for aneuploidy?. Cytogenet Genome Res 133(2-4):280-91.
30. Robbins WA, Elashoff DA, Xun L, Jia J, Li N, Wu G and Wei F (2005) Effect of lifestyle exposures on sperm aneuploidy. Cytogenet Genome Res.;111(3-4):371-7. Review.
31. Pereira CS, Juchniuk de Vozzi MS, Dos Santos SA, Vasconcelos MA, de Paz CC, Squire JA, Martelli L (2014) Smoking-induced chromosomal segregation anomalies identified by FISH analysis of sperm. Mol Cytogenet. 2014 7(1):58
32. Robbins WA, Vine MF, Truong KY, Everson RB (1997) Use of fluorescence in situ hybridization (FISH) to assess effects of smoking, caffeine, and alcohol on aneuploidy load in sperm of healthy men. Environ Mol Mutagen. 30(2):175-83.
33. Jurewicz J Radwan M, Sobala W, Radwan P, , Jakubowski L, Hawula W, Ulanska A, Hanke W (2014) Lifestyle factors and sperm aneuploidy. Reprod Biol 14(3):190-9.
34. Harkonen K (2005) Pesticides and the induction of aneuploidy in human sperm. Ctyogenet. Genome Res. 111 (3-4): 378-83
35. Perry MJ (2008) Effects of environmental and occupational pesticide exposure on human sperm: a systematic review. Hum Reprod Update 14(3):233-42.
36. Radwan M, Jurewicz J, Radwan P, Ulanska A, Jakubowski L, Hanke W (2015) Occupational risk factors and frequency of sex chromosome disomy. Human Fertil (Camb) 18(3):200-7
37. Tempest HG, Ko E, Chan P, Robaire B, Rademaker A, Martin RH (2008) Sperm aneuploidy frequencies analysed before and after chemotherapy in testicular cancer and Hodgkin's lymphoma patientsHum Reprod 23(2):251-258
38. Choy JT, Brannigan RE (2013) The determination of reproductive safety in men during and after cancer treatment. Fertil Steril 100(5):1187-91
39. Emery BR (2013) Sperm aneuploidy testing using fluorescence in situ hybridization. Methods Biol 927:167-73.
40. Ramasamy R, Besada S, Lamb DJ (2014) Fluorescent in situ hybridization of humansperm: diagnostics, indications, and therapeutic implications. Fertil Steril 102(6):1534-9
41. Young SS, Eskenazi B, Marchetti FM, Block G, Wyrobek AJ (2008) The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men. Hum Reprod23(5):1014-22
42. Worrilow KC, Eid S, Woodhouse D, Perloe M, Smith S, Witmyer J, Ivani K, Khoury C, Ball GD, Elliot T, Lieberman J. (2013) Use of hyaluronan in the selection of sperm for intracytoplasmic sperm injection (ICSI): significant improvement in clinical outcomes--multicenter, double-blinded and randomized controlled trial. Hum Reprod. 28 (2):306-14.